5-98779663-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001366508.1(RGMB):c.220G>A(p.Val74Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000959 in 1,574,676 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001366508.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGMB | NM_001366508.1 | c.220G>A | p.Val74Ile | missense_variant | 2/3 | ENST00000513185.3 | NP_001353437.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGMB | ENST00000513185.3 | c.220G>A | p.Val74Ile | missense_variant | 2/3 | 2 | NM_001366508.1 | ENSP00000423256 | ||
RGMB | ENST00000308234.11 | c.343G>A | p.Val115Ile | missense_variant | 4/5 | 1 | ENSP00000308219 | P1 | ||
RGMB | ENST00000434027.2 | n.991G>A | non_coding_transcript_exon_variant | 4/4 | 2 | |||||
RGMB | ENST00000504776.5 | n.624G>A | non_coding_transcript_exon_variant | 4/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000552 AC: 84AN: 152258Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000139 AC: 31AN: 223294Hom.: 0 AF XY: 0.000109 AC XY: 13AN XY: 119594
GnomAD4 exome AF: 0.0000464 AC: 66AN: 1422300Hom.: 0 Cov.: 31 AF XY: 0.0000456 AC XY: 32AN XY: 701814
GnomAD4 genome AF: 0.000558 AC: 85AN: 152376Hom.: 0 Cov.: 33 AF XY: 0.000537 AC XY: 40AN XY: 74516
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at